Propecia and Proscar, commonly prescribed for the treatment of male pattern baldness, have been linked to sexual side effects in men, as well as an increased risk of prostate cancer, leading to product liability lawsuits.
Finasteride, the main ingredient of the drugs, works by preventing the conversion of androgen testosterone to DHT, a hormone that is important for male sexual performance. Side effects of the drugs include persistent sexual dysfunction, including low sexual desire, erectile dysfunction, impotence, problems with orgasms and other related sexual complications.
Scientific studies of these drugs have also linked them to long-term sexual dysfunction, decreased libido, lower sperm count, and difficulty achieving or maintaining an erection. Warnings on the drug's label state that side effects may include sexual dysfunction, but it also states that such dysfunction will resolve after discontinued use of the drug, an assertion that has come under scrutiny based on studies that have come to the opposite conclusion.
In addition, studies have found that the drugs can lower the reading on PSA prostate-cancer screening tests. This means that a person taking Propecia for a year could have a deceptively low PSA result, which could lead to a missed diagnosis.
In June of 2011 the FDA issued a press release advising of a warning-label change on Propecia, Proscar, Avodart, and Jalyn, all 5-alpha reductase inhibitors (5-ARIs) to include "Increased Risk of Prostate Cancer."
According to FDA, approximately 5 million men were prescribed these popular medications between 2002 and 2009.
The defective drug and product liability lawyers at Dreyer Boyajian LLP are prosecuting Propecia lawsuits for men suffering from sexual side effects or prostate cancer. If you or a loved one believes you have a case, call us today at 518-463-7784, or Contact Us through the web, and we will call you.